Should you buy 0R1F.L stock?
Last updated:
Based on market data through , StockInvest.us rates Bristol-Myers Squibb Co. (0R1F.L) as a Buy Candidate with a technical score of 3.06 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Buy signal since
- Price since signal Up 7.45%
- 3-month trend forecast Up 13.56%
- Strong return on equity of 46.8%
- Strong operating margin of 28.3%
- High gross margin of 70.2%
Green day on Monday for Bristol-Myers Squibb Co. stock after gaining 0.93%
(Market data through Aug 10, 2026)
The Bristol-Myers Squibb Co. stock price gained 0.93% on the last trading day (Monday, 10th Aug 2026), rising from $64.30 to $64.90. It has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 2.27% from a day low at $63.97 to a day high of $65.42. The price has risen in 8 of the last 10 days and is up by 4.51% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 7 thousand more shares were traded than the day before. In total, 14 thousand shares were bought and sold for approximately $884.13 thousand.
The stock lies in the upper part of a wide and strong rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $66.04 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 13.56% during the next 3 months and, with a 90% probability hold a price between $65.73 and $75.00 at the end of this 3-month period.
0R1F.L Signals & Forecast
The Bristol-Myers Squibb Co. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $64.49 and $60.06. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Bristol-Myers Squibb Co. has increased volume and follows the last lift in the price. This is considered to be a technical positive sign as volume should follow the price-formation. Higher liquidity also reduces the general risk. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, August 04, 2026, and so far it has fallen -0.99%. Further fall is indicated until a new bottom pivot has been found.
Support, Risk & Stop-loss for Bristol-Myers Squibb Co. stock
Bristol-Myers Squibb Co. finds support from accumulated volume at $64.60 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.45 between high and low, or 2.27%. For the last week, the stock has had daily average volatility of 4.17%.
Our recommended stop-loss: $62.41 (-3.84%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 4 days ago.)
Trading Expectations (0R1F.L) For The Upcoming Trading Day Of Tuesday 11th
For the upcoming trading day on Tuesday, 11th we expect Bristol-Myers Squibb Co. to open at $64.76, and during the day (based on 14 day Average True Range), to move between $63.56 and $66.24, which gives a possible trading interval of +/-$2.69 (+/-4.23%) up or down from last closing price. If Bristol-Myers Squibb Co. takes out the full calculated possible swing range there will be an estimated 4.23% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at $64.60 (0.46%) than the resistance at $65.55 (1.00%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Bristol-Myers Squibb Co. stock A Buy?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Bristol-Myers Squibb Co. stock to perform well in the short-term.
Current score:
3.055
Buy Candidate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 11, 2026 - $64.76 ( 0.211%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
0R1F.L Performance
Trading levels for 0R1F.L
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 66.21 | 2.02% |
| R2 | 65.66 | 1.17% |
| R1 | 65.32 | 0.643% |
| Price | 64.90 | |
| S1 | 64.21 | -1.06% |
| S2 | 63.87 | -1.59% |
| S3 | 63.31 | -2.44% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 0 | - |
| R2 | 0 | - |
| R1 | 65.55 | 1.00% |
| Price | 64.90 | |
| S1 | 64.60 | -0.462% |
| S2 | 57.25 | -11.79% |
| S3 | 55.85 | -13.94% |
0R1F Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Jul 02, 2026 | Jul 02, 2026 | Jul 02, 2026 | $0.630 | 1.12% |
| 2 | Apr 02, 2026 | Apr 02, 2026 | Apr 02, 2026 | $0.630 | 1.03% |
| 3 | Jan 02, 2026 | Jan 02, 2026 | Jan 02, 2026 | $0.630 | 0% |
| 4 | Oct 03, 2025 | Oct 03, 2025 | Oct 03, 2025 | $0.620 | 0% |
| 5 | Jul 03, 2025 | Jul 03, 2025 | Jul 03, 2025 | $0.620 | 0% |
FAQ
Click here for our free guide on how to buy Bristol-Myers Squibb Co. Stock.
Buy 0R1F